Stay updated on CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial
Sign up to get notified when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.

Latest updates to the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page
- Check5 days agoChange DetectedThe page adds quick-access links for eligibility checks and contacting the study team. The revision log now shows a new 3.6.0 release replacing 3.5.5.SummaryDifference0.4%

- Check13 days agoChange DetectedThe page footer's revision was updated from v3.5.4 to v3.5.5, indicating a new build release.SummaryDifference0.1%

- Check20 days agoChange DetectedThe history shows a substantial expansion of the study record with new sections (IPDSharing, Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Oversight, Study Status, Study Identification) added during 2026 updates, alongside a minor capitalization tweak in the title.SummaryDifference1%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry v3.5.4 was added to the Record History, while the previous v3.5.3 entry was removed. This reflects a minor update to the page’s revision trail.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page now displays Revision: v3.5.3 in the footer, replacing the previous Revision: v3.5.2. This indicates a minor update to the page's revision history.SummaryDifference0.1%

- Check62 days agoChange DetectedA new site revision entry (v3.5.2) was added and an older revision (v3.5.0) was removed.SummaryDifference0.1%

Stay in the know with updates to CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CARPALL: CAR T-cells for CD19+ Malignancies Clinical Trial page.